Biotech & Pharma Regulatory Risk: Investor Assessment Strategies
Regulatory risk stands among the most pivotal factors investors assess when directing capital toward biotechnology and pharmaceutical companies, as these sectors rely heavily on government bodies to oversee product authorization,…